Crizotinib-controlled ALK positive disease and three brain metastases

Date 17 April 2015
Event ELCC 2015
Session Multidisciplinary Tumour Board: How do we approach oligoprogressive disease?
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Surgery and/or Radiotherapy of Cancer
Presenter Matthias Guckenberger
Authors M. Guckenberger
  • University Hospital Zurich  , Zurich/CH